[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100628110":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":31,"locations":36,"responsibleParty":51,"collaborators":11,"id":53,"slug":11,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":56,"acronym":11,"eligibilityCriteria":57,"healthyVolunteers":58,"sex":59,"minAge":60,"maxAge":61,"enrollmentInfo":62,"targetDuration":11,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":11,"overallStatus":71,"whyStopped":11,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"University of Minnesota","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Active taVNS","ACTIVE_COMPARATOR",null,[13],"Device: Active taVNS",{"label":15,"type":16,"description":11,"interventionNames":17},"Sham taVNS","PLACEBO_COMPARATOR",[18],"Device: Sham taVNS",[20,24],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":11},"DEVICE","Actual taVNS",[9],{"type":21,"name":15,"description":25,"armGroupLabels":26,"otherNames":11},"No nerve stimulation",[15],[28],{"name":29,"affiliation":5,"role":30},"Mark Hartman, PhD","PRINCIPAL_INVESTIGATOR",[32],{"name":29,"role":33,"phone":34,"phoneExt":11,"email":35},"CONTACT","218-726-7275","hartm373@d.umn.edu",[37],{"facility":38,"status":11,"city":39,"state":40,"zip":41,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"University of Minnesota Duluth","Duluth","Minnesota","55812","United States",{"type":44,"coordinates":45},"Point",[46,47],-92.10658,46.78327,{"lat":47,"lon":46},[50],{"name":29,"role":33,"phone":34,"phoneExt":11,"email":35},{"type":52,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100628110",false,"NCT07457372","How Does Vagus Nerve Stimulation Affect Blood Glucose, Food, and Movement Cravings?","Inclusion Criteria:\n\n* Participants must be between the ages of 18 and 35 as we are focused on recruiting undergraduate and graduate students.\n\nExclusion Criteria:\n\n* Participants will be excluded if they have epilepsy, clinically significant tachycardia or arrhythmia, diabetes (Type 1 or Type 2) or another metabolic disease, current pregnancy, any implanted electronic medical device (for example, pacemaker or defibrillator), or a known skin allergy to adhesives that would prevent CGM placement. Participants will also be excluded if they have a history of major depressive disorder if taVNS could reasonably be expected to alter mood symptoms",true,"ALL","18 Years","35 Years",{"count":63,"type":64},8,"ESTIMATED","INTERVENTIONAL",[67],"NA","The purpose of this study is to determine the feasibility of using non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) to examine physiological and psychological responses in a college-aged healthy population",[70],"Vagus Nerve Stimulation","NOT_YET_RECRUITING","2026-05-18",{"date":74,"type":75},"2026-05-20","ACTUAL",{"date":77,"type":64},"2026-07-01",{"date":79,"type":64},"2028-05-01",{"name":5,"class":6},1]